Pathological Complete Response Induced by the Combination Therapy of S-1 and 24-h Infusion of Cisplatin in Two Cases Initially Diagnosed As Inoperable Advanced Gastric Cancer
Authors
Affiliations
We report on two patients, successfully treated by the combination therapy of S-1 and 24-h infusion of cisplatin (CDDP), who were initially diagnosed with unresectable stage 4 advanced gastric cancer. Each patient had a very good clinical response and underwent curative gastrectomy after completion of 14 and 10 courses of S-1/CDDP chemotherapy, respectively. A microscopically detailed examination of surgically obtained specimens showed the complete disappearance of malignant cells in the two cases. S-1/CDDP combination therapy can, therefore, be highly active in incurable advanced gastric carcinoma.
Kawai J, Yasufuku I, Fukada M, Asai R, Sato Y, Tajima Y Surg Case Rep. 2024; 10(1):138.
PMID: 38837046 PMC: 11153382. DOI: 10.1186/s40792-024-01929-3.
Chemo-Immunotherapy Using Lentinan for the Treatment of Gastric Cancer with Liver Metastases.
Ina K, Furuta R, Kataoka T, Kayukawa S, Ina H, Yoneda M Med Sci (Basel). 2017; 4(2).
PMID: 29083372 PMC: 5635777. DOI: 10.3390/medsci4020008.
The use of lentinan for treating gastric cancer.
Ina K, Kataoka T, Ando T Anticancer Agents Med Chem. 2012; 13(5):681-8.
PMID: 23092289 PMC: 3664515. DOI: 10.2174/1871520611313050002.
Lentinan prolonged survival in patients with gastric cancer receiving S-1-based chemotherapy.
Ina K, Furuta R, Kataoka T, Kayukawa S, Yoshida T, Miwa T World J Clin Oncol. 2011; 2(10):339-43.
PMID: 21994907 PMC: 3191325. DOI: 10.5306/wjco.v2.i10.339.